Author:
Panorchan Kwanpeemai,Davenport Andrew
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Koomen GCM, Betjes MGH, Zemel D, Krediet RT, Hoek FJ: Dialysate cancer antigen (CA) 125 is a reflection of the peritoneal mesothelial mass in CAPD patients. Perit Dial Int. 1994, 14: 132-6.
2. Visser CE, Brouwer-Steenbergen JJ, Betjes MG, Koomen GC, Beeleen RH, Krediet RT: Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant. 1995, 10: 64-9.
3. Krediet RT: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int. 2001, 21: 560-7.
4. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT: Longitudinal follow-up of CA-125 in peritoneal effluent. Kidney Int. 1997, 51: 888-93.
5. Habib AM, Preston E, Davenport A: Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription. Nephrol Dial Transplant. 2010, 25 (5): 1633-8.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献